$36 Million California Plan Moves Forward to Boost Patients into Stem Cell/Gene Therapy Trials
Proposal dismays an applicant in earlier, similar CIRM round replete with unusual circumstances

A $36 million plan to bring clinical trials for gene and stem cell therapies to patients in underserved and more remote areas of California cleared a key hurdle yesterday afternoon, but not without some complaint.
The program would be launc…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.